Published in Med J Aust on August 20, 1966
Cystic adventitial disease of the popliteal artery. Br Med J (1967) 1.59
Summary of cases of adventitial cystic disease of the popliteal artery. Ann Surg (1979) 1.19
Doppler ultrasonography and exercise testing in diagnosing a popliteal artery adventitial cyst. Cardiovasc Ultrasound (2009) 0.98
Arterial cystic degeneration. Postgrad Med J (1972) 0.77
Deviation from the universal code shown by the gene for surface protein 51A in Paramecium. Nature (1985) 2.33
A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis. J Immunol (1986) 1.19
Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases. Med J Aust (1978) 1.17
Ocular involvement in scleroderma. Br J Ophthalmol (1979) 1.15
Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger? Postgrad Med J (1991) 1.11
Medial patellofemoral ligament reconstruction: a prospective outcome assessment of a large single centre series. J Bone Joint Surg Br (2012) 1.05
Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases. Med J Aust (1969) 1.05
Cartilage-bone mismatch in the dysplastic trochlea. An MRI study. J Bone Joint Surg Br (2006) 1.02
Application of neural networks and sensitivity analysis to improved prediction of trauma survival. Comput Methods Programs Biomed (2000) 1.01
Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis. J Immunol (1986) 0.99
Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. J Neurol Neurosurg Psychiatry (1991) 0.98
Scleroderma. 2. Incidence of systemic disturbance and assessment of possible aetiological factors. Med J Aust (1969) 0.97
Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis. Clin Exp Immunol (1986) 0.92
Observations on the hypotensive action of "Catapres" (ST 155) in man. Med J Aust (1968) 0.91
Autoantibodies in scleroderma. Med J Aust (1968) 0.90
Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study. Med J Aust (1978) 0.88
Medical treatment of hypertension and renal failure in scleroderma. Aust N Z J Med (1981) 0.88
Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV. J Infect (2002) 0.88
Genetic factors in myasthenia gravis: a family study. Neurology (1988) 0.87
Neurotrophin expression in the adult olfactory epithelium. Brain Res (2007) 0.85
Autoantibodies to fibroblasts in scleroderma. J Clin Lab Immunol (1982) 0.85
An evaluation of the British Pharmacopoeial assay of heparin: a comparison with other methods. J Clin Pathol (1980) 0.85
Lower limb amputation in a general hospital: a comparative review. Med J Aust (1976) 0.85
Clinical and radiological results of the collarless polished tapered stem at 15 years follow-up. J Bone Joint Surg Br (2012) 0.85
Spontaneous resolution of carotid stenosis--a case for routine preoperative duplex ultrasound. Eur J Vasc Endovasc Surg (2005) 0.83
Renal immune deposits in scleroderma. Pathology (1971) 0.82
Haematological effects of methyldopa. Lancet (1967) 0.82
The systemic involvement in scleroderma. Med J Aust (1977) 0.81
Arterial reconstruction extending below the popliteal bifurcation. Br J Surg (1978) 0.80
Acquired Brown's syndrome. Ann Rheum Dis (1993) 0.80
Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada. Int Psychogeriatr (1999) 0.80
Pharmacokinetics of methyldopa. Plasma levels following single intravenous, oral and multiple oral dosage in normotensive and hypertensive subjects. Clin Exp Pharmacol Physiol (1977) 0.79
Long-term results of treatment of severe hypertension. Med J Aust (1973) 0.79
Iidopathic orthostatic hypotension: a pharmacological study of the action of sympathomimetic drugs. Med J Aust (1968) 0.78
Polymyositis as a cause of total gut failure. Ann Rheum Dis (2002) 0.78
Motor neuron disease with neurofibrillary tangles in a non-Guamanian patient. Acta Neuropathol (1995) 0.76
Aspirin, phenacetin, and the kidney: a rheumatism clinic study. Med J Aust (1977) 0.76
The "neck sign" in scleroderma. Arthritis Rheum (1989) 0.76
Mexiletine clearance during peritoneal dialysis. Br J Clin Pharmacol (1985) 0.75
Letter: Hazards of popliteal aneurysms. Med J Aust (1975) 0.75
Bilateral cervical rib and subclavian aneurysm. Aust N Z J Surg (1973) 0.75
Letter: Idiopathic orthostatic hypotension. Med J Aust (1976) 0.75
Trial of a new hypotensive drug--clonidine ("catapres"). Med J Aust (1970) 0.75
Renal artery digital-subtraction angiography. An outpatient investigation for renovascular hypertension. Med J Aust (1985) 0.75
John Maurice Davies. Med J Aust (1973) 0.75
Treatment of resistant oedema with new diuretics: ethacrynic acid and frusemide. Med J Aust (1965) 0.75
Salazopyrin in the treatment of scleroderma. Australas J Dermatol (1975) 0.75
Current status of treatment of severe hypertension. Med J Aust (1976) 0.75
Darkening of white hair in Parkinson's disease. Clin Exp Dermatol (1989) 0.75
Trial of "Atheran" and "Atromid-S" in atherosclerosis. Med J Aust (1966) 0.75
Cardiac involvement in severe hypertension. Singapore Med J (1973) 0.75
Observation of electro-optic and electroabsorption modulation in a Langmuir-Blodgett film Fabry-Perotétalon. Opt Lett (1995) 0.75
Results of surgical treatment of occlusive arterial disease affecting the lower limbs, 1953-1967. Med J Aust (1970) 0.75
Some observations on the immunological status in scleroderma (progressive systemic sclerosis). Aust N Z J Med (1978) 0.75
The new feminism--and men. Med J Aust (1977) 0.75
Treatment of scleroderma. Med J Aust (1977) 0.75
George Alexander Birnie. Med J Aust (1979) 0.75
Spironolactone induced agranulocytosis. Med J Aust (1994) 0.75
The skin changes in scleroderma (systemic sclerosis). Australas J Dermatol (1980) 0.75
A psychological approach to pregnancy and childbirth. Some of the aspects which should concern midwives. Midwives Chron (1977) 0.75
Modern diuretic therapy. J Indian Med Prof (1965) 0.75
Norethisterone acetate in the treatment of scleroderma. Australas J Dermatol (1975) 0.75
Scleroderma (progressive systemic sclerosis) with severe bowel involvement. Treatment by extensive resection of the small intestine. Aust N Z J Med (1976) 0.75
Immunology in scleroderma. Med J Aust (1978) 0.75